Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance - Wikidata - awgldk - TriplyDB

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

http://www.wikidata.org/entity/Q36480301

about

By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.Clinicopathological and prognostic significance of metastasis-associated protein 1 expression and its correlation with angiogenesis in lung invasive adenocarcinomas, based on the 2011 IASLC/ATS/ERS classification.Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma.RETRACTED: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells.The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis.Overexpression of Ku80 correlates with aggressive clinicopathological features and adverse prognosis in esophageal squamous cell carcinoma XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma.Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa.MDM2 binding protein as a predictor of metastasis and a novel prognostic biomarker in patients with gastric cancer.Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients.Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma.Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer

P2860

Q35176335-83B7703B-011E-45E1-A55C-8C1D9DE02F30 Q36291991-EBD4E54B-5DDC-4378-A315-AD74DD60B84F Q36502784-AB6B2F7D-1E74-4042-99C4-FAFD56B5AC5A Q36851857-46A05BF8-D744-4993-952B-7610D7D8E4AC Q37283871-0B3BB7E8-47E0-4644-B610-71C7F8E50A56 Q37330849-995BA9B1-42EE-4394-951E-8CBC1D1FBBBE Q37747947-87808D57-655E-47B6-A53E-F347743C4E66 Q38690281-F730DED8-9040-4B72-B558-FA01CAFB8818 Q39003101-A65D96BE-FEF7-42E9-A3F0-27B678C983A6 Q41252181-397E5400-4CF9-49A3-9FDE-FDD66687692E Q41715562-CE6779E5-A858-4B44-8B7B-39F0F485389B Q42016675-B81CEE33-3F2E-493E-9078-06E7065C4CFF Q46039292-D569ED8E-7726-4F5A-8EB1-BE6B69D03613 Q47131381-07607614-1D1A-42F5-A3D8-0ACE01DE7B6D Q48027188-0736F369-D10F-4023-A82F-0D933F647295 Q48521555-1BAD2ABF-02F6-476E-8E80-BF3A9D02EA95 Q49758231-F736B0B3-E7A1-4BD4-8FAB-8C7084934D0C Q53598546-0BA85680-5F57-4D17-B6A8-68BB2C7A08F8 Q55261738-6ADC344D-8C6B-4A19-B9EF-194EB08BA588 Q58741539-6FC1004A-5317-40C4-B423-AE3ED8B7C2D5

P2860

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

http://www.wikidata.org/entity/Q36480301

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@ast

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@en

type

label

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@ast

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@en

prefLabel

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@ast

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@en

P1433

Q36480301-3731A14E-76C5-4C1F-ABD9-113C5828E997

P1476

Q36480301-56169496-829B-40D1-902A-601CC34CF2D3

P2093

Q36480301-055565F8-6E5E-4874-89F5-27D09E17E69A

Q36480301-08C8512D-573D-4209-8C84-F225AFC28FDD

Q36480301-2C1447FE-EDA5-44A2-8418-A23B4C0FA28C

Q36480301-85504D77-4D64-429C-B548-F75F4EC7CB70

Q36480301-967E6AA9-6B93-4419-9AB3-84F9CB1BA682

Q36480301-CCB913F6-DF4B-474C-9088-4D8894712655

Q36480301-CFBD638C-D3CE-45C6-84EF-D38C2BC946CD

P2860

Q36480301-1236D70E-27D2-439C-8056-2107A8E34F3C

Q36480301-1AC19FDC-4A8C-4699-968E-F46F80F78EFA

Q36480301-32D7D33D-572A-4E2F-AAB7-9C6176F2CF98

Q36480301-33BAC47D-C1A8-47BB-8A60-7771295F431D

Q36480301-3FEABB89-8FE1-489A-8E9D-1E208907A725

Q36480301-49B4E08C-EC5F-4E11-81A2-E38F8E0EEFEE

Q36480301-4BCB6435-0EDD-4A8B-A015-282E124C3EBD

Q36480301-56BAEE7B-EFEB-478E-9CCD-571B0F8A807F

Q36480301-66BF7D98-7EF7-4C4A-915D-5E06BA6A17D2

Q36480301-7A394E6B-BE95-46F5-A2E1-399732BCE812

P2888

Q36480301-4BE415AE-CC14-494F-8225-BE9A8EC54DA6

P304

Q36480301-DDFAC1E5-3298-4C9E-8CE2-A0C3DAAC5EE6

P31

Q36480301-6BFE377A-4A89-4264-BA98-97872A72C9A4

P356

Q36480301-7EC9D6D2-3664-4FF7-9121-DB74972B1D39

P478

Q36480301-9EFA68FB-1D36-4352-B854-3F1362029164

P577

Q36480301-F5E3200E-9D07-4ABA-A9F9-2835EF11EB98

P5875

Q36480301-1ECD61EE-841C-408C-BBF3-1D196FF0C75A

P6179

Q36480301-34A639C5-F537-438E-8B86-145E944BE4A7

P698

Q36480301-D2FC558E-B690-46BF-AC9D-9E507458F671

P921

Q36480301-A1D881D3-9624-402A-8E70-1A1BBEE59ABE

P932

Q36480301-E98D021E-8B32-49F9-858E-1FF09C05F838

P356

1756-9966-31-99

P1433

Journal of Experimental & Clinical Cancer Research

P1476

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

@en

P2093

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Jinzhi Yin

http://www.w3.org/2001/XMLSchema#string

Minyu Xu

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Qingshan Ma

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Zhenzhong Su

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Ku86 is essential in human somatic cells.

Apoptosis: a link between cancer genetics and chemotherapy.

The resurgence of platinum-based cancer chemotherapy.

Ku80 removal from DNA through double strand break-induced ubiquitylation.

Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.

Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer.

P2888

1756-9966-31-99

P304

99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-9966-31-99

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233771664

http://www.w3.org/2001/XMLSchema#string

P6179

1044181938

http://www.w3.org/2001/XMLSchema#string

P698

23181744

http://www.w3.org/2001/XMLSchema#string

P921

P932

3527197

http://www.w3.org/2001/XMLSchema#string